1-year, Prospective, Randomized, Open-label, Parallel Group Observational Study to Evaluate the Safety and Efficacy of 4mg/Day of Pitavastatin Versus 2mg/Day of Pitavastatin in Acute Myocardial Infarction(AMI).

Trial Profile

1-year, Prospective, Randomized, Open-label, Parallel Group Observational Study to Evaluate the Safety and Efficacy of 4mg/Day of Pitavastatin Versus 2mg/Day of Pitavastatin in Acute Myocardial Infarction(AMI).

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Dec 2014

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Cardiovascular disorders; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms LAMIS
  • Sponsors JW Pharmaceutical
  • Most Recent Events

    • 14 Dec 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 12 May 2014 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 04 Oct 2012 Planned end date changed from 1 Sep 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top